Moreover, the NCL inhibitor AS1411 inhibited the proliferation of human glioma and breast cancer cells via the destabilization and downregulation of Bcl‐2 mRNA (Y. Cheng et al., 2016; Soundararajan et al., 2008). Here, BCL2 is linked to central nervous system cancer.